Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Neuromyelitis Optica and Pregnancy Publisher Pubmed



Zareshahabadi A1, 2 ; Langroodi HG1 ; Azimi AR1 ; Sahraian MA1 ; Harirchian MH3 ; Baghbanian SM4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, MS Research Center, Neuroscience Institute, Sina Hospital, Tehran University of Medical Science, Imam Khomeini Ave., Hasan Abad Sq., Tehran, Iran
  2. 2. Psychiatry and Psychology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Iranian Center of Neurological Researches, Imam Khomeini Hospital, Tehran University of Medical Science, Keshavarz Blvd., Tehran, Iran
  4. 4. Neurology Department, Booalisina Hospital, Mazandaran University of Medical Science, Pasdaran Boulevard, Sari, Iran

Source: Acta Neurologica Belgica Published:2016


Abstract

Neuromyelitis optica (NMO) and the associated NMO spectrum disorders are demyelinating disorders affecting the spinal cord and optic nerves. It has prominent female predominance and many of these patients are in their childbearing years. As pregnancy seems to have a major impact on this disease course, in this review, recent studies with a focus on this disease and pregnancy and safety of available treatment options during this period are discussed. © 2016, Belgian Neurological Society.
Related Docs
View other Related Docs
1. A Comparison of Pediatric and Adult Neuromyelitis Optica Spectrum Disorders: A Review of Clinical Manifestation, Diagnosis, and Treatment, Journal of the Neurological Sciences (2018)
2. Autoimmune Diseases Associated With Neuromyelitis Optica Spectrum Disorders: A Literature Review, Multiple Sclerosis and Related Disorders (2019)
3. Iranian Consensus Recommendations for Treatment of Myasthenia Gravis, Archives of Iranian Medicine (2022)
4. Management of Pemphigus Disease in Pregnancy, American Journal of Reproductive Immunology (2017)
5. Environmental and Genetic Risk Factors in the Development of Neuromyelitis Optica, Expert Review of Ophthalmology (2020)
6. Efficacy and Safety of Rituximab in Patients With Refractory Neuromyelitis Optica Spectrum Disorders: A Prospective Observation in Iranian Cases, Caspian Journal of Internal Medicine (2020)
7. Optical Coherence Tomography Angiography Measurements in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Disease: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2024)
8. Disability and Therapeutic Response in Paediatric Neuromyelitis Optica Spectrum Disorder a Case Series From Iran, Iranian Journal of Child Neurology (2019)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (12)
Abdolreaza Naser Moghadasi (11)
Other Related Docs
9. Diagnosis and Management of Neuromyelitis Optica Spectrum Disorder (Nmosd) in Iran: A Consensus Guideline and Recommendations, Multiple Sclerosis and Related Disorders (2017)
10. Exploring the Association of Reproductive History With the Development and Course of Neuromyelitis Optica Spectrum Disorder, Clinical Neurology and Neurosurgery (2022)
11. Effect of Ginseng on Fatigue Related to Neuromyelitis Optica Spectrum Disorder: A Double-Blinded Randomized Controlled Clinical Trial, Caspian Journal of Internal Medicine (2024)
12. Neuromyelitis Optica Spectrum Disorders in Iran, Multiple Sclerosis and Related Disorders (2017)
13. Environmental Risk Factors in Neuromyelitis Optica Spectrum Disorder: A Case–Control Study, Acta Neurologica Belgica (2018)
14. Microorganisms in Pathogenesis and Management of Neuromyelitis Optica Spectrum Disorder, Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases: Volume II: Kidney# Central Nervous System# Eye# Blood# Blood Vessels and Bowel (2023)
15. The Possible Role of Interleukin-6 As a Regulator of Insulin Sensitivity in Patients With Neuromyelitis Optica Spectrum Disorder, BMC Neurology (2021)
16. Elevated Serum Level of Il-4 in Neuromyelitis Optica and Multiple Sclerosis Patients, Journal of Immunoassay and Immunochemistry (2019)
17. Neuromyelitis Optica Spectrum Disorder (Nmosd) Associated With Cancer: A Systematic Review, Multiple Sclerosis and Related Disorders (2021)
18. Higher Disease and Pain Severity and Fatigue and Lower Balance Skills Are Associated With Higher Prevalence of Falling Among Individuals With the Inflammatory Disease of Neuromyelitis Optica Spectrum Disorder (Nmosd), Journal of Clinical Medicine (2020)
19. A Comprehensive Review of Rituximab Therapy in Rheumatoid Arthritis Patients, Clinical Rheumatology (2019)
20. Sleep Disorders As a Possible Predisposing Attack Factor in Neuromyelitis Optica Spectrum Disorder (Nmosd): A Case-Control Study, Clinical Neurology and Neurosurgery (2021)
21. Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (Nmosd) Five Years After Disease Onset, Journal of Clinical Medicine (2022)